The neurointerventional devices market size has grown strongly in recent years. It will grow from $2.76 billion in 2025 to $2.97 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising prevalence of stroke and aneurysm, improvements in catheter and stent design, increasing neurology specialist training programs, growing adoption of minimally invasive procedures, expansion of hospital neurovascular departments.
The neurointerventional devices market size is expected to see strong growth in the next few years. It will grow to $3.91 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to aging population growth, increasing investments in neurovascular research, expansion of comprehensive stroke centers, demand for faster reperfusion outcomes, rising healthcare expenditure in emerging economies. Major trends in the forecast period include advanced image-guided neurointervention, shift toward minimally invasive stroke treatment, rising adoption of flow diversion technologies, increasing demand for rapid clot retrieval devices, expansion of neurointerventional procedures in emerging markets.
The increasing prevalence of neurological disorders is anticipated to drive the growth of the neurointerventional devices market in the coming years. A neurological disorder is any condition that impacts the brain, spinal cord, or nerves, interfering with normal neurological function. The rise in neurological disorders is largely attributed to the aging global population, as older age elevates the risk of neurodegenerative diseases due to the gradual decline in brain function and reduced cellular repair capacity. Neurointerventional devices assist in the treatment of neurological disorders by supporting minimally invasive procedures used to diagnose and manage conditions such as strokes, brain aneurysms, and vascular malformations, thereby lowering procedural risks, shortening recovery time, and enhancing patient outcomes. For example, in April 2024, a report published by the Alzheimer’s Association, a US-based nonprofit voluntary health organization, stated that in 2022, approximately 6.5 million Americans aged 65 and above were living with Alzheimer’s dementia, a number that rose to 6.9 million by 2024. As a result, the growing incidence of neurological disorders is fueling the expansion of the neurointerventional devices market.
Major companies active in the neurointerventional devices market are concentrating on the development of innovative solutions, including large-bore aspiration reperfusion catheters supported by advanced delivery technologies. Aspiration reperfusion catheters are elongated, large-lumen, and highly flexible devices designed to provide strong distal vacuum aspiration directly at the site of the clot; unlike conventional stent-retriever approaches, they prioritize direct aspiration - sometimes used alongside adjunctive tools - to clear occlusions with fewer passes, reduced device complexity at the clot interface, and potentially faster procedural workflows. For example, in May 2024, Penumbra Inc., a US-based medical device company, introduced RED 43, RED 72 with SENDit Technology, and RED 78 in Europe, expanding its portfolio of aspiration-based thrombectomy solutions. The RED catheters feature multi-layer shaft constructions incorporating PTFE liners, hybrid stainless steel and nitinol coils, and precision-engineered polymer distal tips to achieve an optimal balance between lumen diameter and distal navigability; they operate by positioning the catheter at or near the thrombus and applying aspiration through Penumbra’s ENGINE aspiration system to remove the clot. Distinctive attributes include engineered transition zones, REDglide technology to enhance navigation through tortuous vasculature, and availability across multiple lumen sizes.
In September 2024, Boston Scientific, a US-based medical technology company, acquired Silk Road Medical for approximately $1.18 billion. Through this acquisition, Boston Scientific aims to broaden its vascular surgery portfolio, strengthen its stroke prevention offerings, and accelerate its mission to transform treatment approaches for vascular disease. Silk Road Medical is a US-based company specializing in medical devices such as transcarotid artery revascularization systems, including the ENROUTE transcarotid neuroprotection and stent systems.
Major companies operating in the neurointerventional devices market are Medtronic plc, Stryker Corporation, Johnson And Johnson, Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Kaneka Corporation, Cook Medical LLC, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co Ltd, MicroVention Inc, Phenox GmbH, Balt Group SAS, Balton Sp z o o, Zylox Tonbridge Medical Technology Co Ltd, Veiva Scientific Co Ltd, InspireMD Inc, Rapid Medical Ltd, Wallaby Medical, Cerus Endovascular Ltd.
North America was the largest region in the neurointerventional market in 2025. The regions covered in the neurointerventional devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurointerventional devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the neurointerventional devices market by increasing costs of imported precision components such as stents, coils, and microcatheters, thereby affecting pricing and procurement strategies for hospitals. The impact is most evident across high-value product segments including flow diverters and thrombectomy devices, with Asia-Pacific and North America being the most affected regions due to manufacturing and trade dependencies. Tariff pressures have also caused delays in supply chains and regulatory clearances. However, these tariffs have encouraged localized manufacturing, regional sourcing, and strategic partnerships, supporting long-term market resilience and domestic production capabilities.
The neurointerventional devices market research report is one of a series of new reports that provides neurointerventional devices market statistics, including neurointerventional devices industry global market size, regional shares, competitors with a neurointerventional devices market share, detailed neurointerventional devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurointerventional devices industry. This neurointerventional devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurointerventional devices are specialized medical instruments designed for minimally invasive procedures aimed at diagnosing and treating disorders of the blood vessels in the brain, spine, head, and neck. Their main function is to restore or enhance blood flow, remove clots, repair aneurysms, or address vascular malformations without requiring open surgery.
The primary types of neurointerventional devices include embolic coils, carotid stents, intracranial stents, neurovascular thrombectomy devices, embolic protection devices, flow diverters, intrasaccular devices, and others. Embolic coils are small, flexible metal devices used to block blood flow within aneurysms or abnormal vessels, encouraging clot formation to prevent rupture or bleeding. These devices are indicated for conditions such as brain aneurysms and strokes and are utilized through techniques like neurothrombectomy, cerebral angiography, stenting, coiling procedures, and flow disruption. The main end users consist of hospitals, ambulatory surgical centers, specialty clinics, and research institutions.
The neurointerventional devices market consists of sales of catheters, stents, embolic coils, thrombectomy devices, and guidewires. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The neurointerventional devices market size is expected to see strong growth in the next few years. It will grow to $3.91 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to aging population growth, increasing investments in neurovascular research, expansion of comprehensive stroke centers, demand for faster reperfusion outcomes, rising healthcare expenditure in emerging economies. Major trends in the forecast period include advanced image-guided neurointervention, shift toward minimally invasive stroke treatment, rising adoption of flow diversion technologies, increasing demand for rapid clot retrieval devices, expansion of neurointerventional procedures in emerging markets.
The increasing prevalence of neurological disorders is anticipated to drive the growth of the neurointerventional devices market in the coming years. A neurological disorder is any condition that impacts the brain, spinal cord, or nerves, interfering with normal neurological function. The rise in neurological disorders is largely attributed to the aging global population, as older age elevates the risk of neurodegenerative diseases due to the gradual decline in brain function and reduced cellular repair capacity. Neurointerventional devices assist in the treatment of neurological disorders by supporting minimally invasive procedures used to diagnose and manage conditions such as strokes, brain aneurysms, and vascular malformations, thereby lowering procedural risks, shortening recovery time, and enhancing patient outcomes. For example, in April 2024, a report published by the Alzheimer’s Association, a US-based nonprofit voluntary health organization, stated that in 2022, approximately 6.5 million Americans aged 65 and above were living with Alzheimer’s dementia, a number that rose to 6.9 million by 2024. As a result, the growing incidence of neurological disorders is fueling the expansion of the neurointerventional devices market.
Major companies active in the neurointerventional devices market are concentrating on the development of innovative solutions, including large-bore aspiration reperfusion catheters supported by advanced delivery technologies. Aspiration reperfusion catheters are elongated, large-lumen, and highly flexible devices designed to provide strong distal vacuum aspiration directly at the site of the clot; unlike conventional stent-retriever approaches, they prioritize direct aspiration - sometimes used alongside adjunctive tools - to clear occlusions with fewer passes, reduced device complexity at the clot interface, and potentially faster procedural workflows. For example, in May 2024, Penumbra Inc., a US-based medical device company, introduced RED 43, RED 72 with SENDit Technology, and RED 78 in Europe, expanding its portfolio of aspiration-based thrombectomy solutions. The RED catheters feature multi-layer shaft constructions incorporating PTFE liners, hybrid stainless steel and nitinol coils, and precision-engineered polymer distal tips to achieve an optimal balance between lumen diameter and distal navigability; they operate by positioning the catheter at or near the thrombus and applying aspiration through Penumbra’s ENGINE aspiration system to remove the clot. Distinctive attributes include engineered transition zones, REDglide technology to enhance navigation through tortuous vasculature, and availability across multiple lumen sizes.
In September 2024, Boston Scientific, a US-based medical technology company, acquired Silk Road Medical for approximately $1.18 billion. Through this acquisition, Boston Scientific aims to broaden its vascular surgery portfolio, strengthen its stroke prevention offerings, and accelerate its mission to transform treatment approaches for vascular disease. Silk Road Medical is a US-based company specializing in medical devices such as transcarotid artery revascularization systems, including the ENROUTE transcarotid neuroprotection and stent systems.
Major companies operating in the neurointerventional devices market are Medtronic plc, Stryker Corporation, Johnson And Johnson, Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Kaneka Corporation, Cook Medical LLC, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co Ltd, MicroVention Inc, Phenox GmbH, Balt Group SAS, Balton Sp z o o, Zylox Tonbridge Medical Technology Co Ltd, Veiva Scientific Co Ltd, InspireMD Inc, Rapid Medical Ltd, Wallaby Medical, Cerus Endovascular Ltd.
North America was the largest region in the neurointerventional market in 2025. The regions covered in the neurointerventional devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurointerventional devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the neurointerventional devices market by increasing costs of imported precision components such as stents, coils, and microcatheters, thereby affecting pricing and procurement strategies for hospitals. The impact is most evident across high-value product segments including flow diverters and thrombectomy devices, with Asia-Pacific and North America being the most affected regions due to manufacturing and trade dependencies. Tariff pressures have also caused delays in supply chains and regulatory clearances. However, these tariffs have encouraged localized manufacturing, regional sourcing, and strategic partnerships, supporting long-term market resilience and domestic production capabilities.
The neurointerventional devices market research report is one of a series of new reports that provides neurointerventional devices market statistics, including neurointerventional devices industry global market size, regional shares, competitors with a neurointerventional devices market share, detailed neurointerventional devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurointerventional devices industry. This neurointerventional devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurointerventional devices are specialized medical instruments designed for minimally invasive procedures aimed at diagnosing and treating disorders of the blood vessels in the brain, spine, head, and neck. Their main function is to restore or enhance blood flow, remove clots, repair aneurysms, or address vascular malformations without requiring open surgery.
The primary types of neurointerventional devices include embolic coils, carotid stents, intracranial stents, neurovascular thrombectomy devices, embolic protection devices, flow diverters, intrasaccular devices, and others. Embolic coils are small, flexible metal devices used to block blood flow within aneurysms or abnormal vessels, encouraging clot formation to prevent rupture or bleeding. These devices are indicated for conditions such as brain aneurysms and strokes and are utilized through techniques like neurothrombectomy, cerebral angiography, stenting, coiling procedures, and flow disruption. The main end users consist of hospitals, ambulatory surgical centers, specialty clinics, and research institutions.
The neurointerventional devices market consists of sales of catheters, stents, embolic coils, thrombectomy devices, and guidewires. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Neurointerventional Devices Market Characteristics
3. Neurointerventional Devices Market Supply Chain Analysis
4. Global Neurointerventional Devices Market Trends and Strategies
5. Neurointerventional Devices Market Analysis of End Use Industries
7. Global Neurointerventional Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Neurointerventional Devices Total Addressable Market (TAM) Analysis for the Market
9. Neurointerventional Devices Market Segmentation
10. Neurointerventional Devices Market Regional and Country Analysis
11. Asia-Pacific Neurointerventional Devices Market
12. China Neurointerventional Devices Market
13. India Neurointerventional Devices Market
14. Japan Neurointerventional Devices Market
15. Australia Neurointerventional Devices Market
16. Indonesia Neurointerventional Devices Market
17. South Korea Neurointerventional Devices Market
18. Taiwan Neurointerventional Devices Market
19. South East Asia Neurointerventional Devices Market
20. Western Europe Neurointerventional Devices Market
21. UK Neurointerventional Devices Market
22. Germany Neurointerventional Devices Market
23. France Neurointerventional Devices Market
24. Italy Neurointerventional Devices Market
25. Spain Neurointerventional Devices Market
26. Eastern Europe Neurointerventional Devices Market
27. Russia Neurointerventional Devices Market
28. North America Neurointerventional Devices Market
29. USA Neurointerventional Devices Market
30. Canada Neurointerventional Devices Market
31. South America Neurointerventional Devices Market
32. Brazil Neurointerventional Devices Market
33. Middle East Neurointerventional Devices Market
34. Africa Neurointerventional Devices Market
36. Neurointerventional Devices Market Competitive Landscape and Company Profiles
37. Neurointerventional Devices Market Other Major and Innovative Companies
40. Neurointerventional Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Neurointerventional Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses neurointerventional devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for neurointerventional devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurointerventional devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Embolic Coils; Carotid Stents; Intracranial Stents; Neurovascular Thrombectomy; Embolic Protection Device; Flow Diverters Device; Intrasaccular Device; Other Products2) By Indication: Brain Aneurysm; Stroke; Other Indications
3) By Technique: Neurothrombectomy Procedure; Cerebral Angiography; Stenting; Coiling Procedures; Flow Disruption
4) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Research Institutes
Subsegments:
1) By Embolic Coils: Bare Platinum Coils; Coated Or Modified Coils; Complex-Shaped Coils; Detachable Coils2) By Carotid Stents: Open-Cell Stents; Closed-Cell Stents; Hybrid-Cell Stents; Drug-Eluting Stents
3) By Intracranial Stents: Self-Expanding Stents; Balloon-Expandable Stents; Drug-Eluting Stents
4) By Neurovascular Thrombectomy Devices: Stent Retrievers; Aspiration Catheters; Combined Thrombectomy Systems
5) By Embolic Protection Devices: Distal Filters; Proximal Occlusion Devices; Distal Occlusion Devices
6) By Flow Diverters Devices: Braided Flow Diverters; Dual-Layer Flow Diverters; Coated Flow Diverters
7) By Intrasaccular Devices: Woven Mesh Implants; Expandable Mesh Baskets; Flow Disrupting Implants
8) By Other Products: Microcatheters; Guidewires; Balloon Catheters; Distal Access Catheters
Companies Mentioned: Medtronic plc; Stryker Corporation; Johnson And Johnson; Abbott Laboratories; Boston Scientific Corporation; Terumo Corporation; Kaneka Corporation; Cook Medical LLC; Merit Medical Systems Inc.; MicroPort Scientific Corporation; Penumbra Inc.; Asahi Intecc Co Ltd; MicroVention Inc; Phenox GmbH; Balt Group SAS; Balton Sp z o o; Zylox Tonbridge Medical Technology Co Ltd; Veiva Scientific Co Ltd; InspireMD Inc; Rapid Medical Ltd; Wallaby Medical; Cerus Endovascular Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Neurointerventional Devices market report include:- Medtronic plc
- Stryker Corporation
- Johnson And Johnson
- Abbott Laboratories
- Boston Scientific Corporation
- Terumo Corporation
- Kaneka Corporation
- Cook Medical LLC
- Merit Medical Systems Inc.
- MicroPort Scientific Corporation
- Penumbra Inc.
- Asahi Intecc Co Ltd
- MicroVention Inc
- Phenox GmbH
- Balt Group SAS
- Balton Sp z o o
- Zylox Tonbridge Medical Technology Co Ltd
- Veiva Scientific Co Ltd
- InspireMD Inc
- Rapid Medical Ltd
- Wallaby Medical
- Cerus Endovascular Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.97 Billion |
| Forecasted Market Value ( USD | $ 3.91 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
